Distribution of GAD-like immunoreactivity in the retina and central visual system of Rana pipiens

Immunohistochemistry was used to survey the distribution of glutamic acid decarboxylase (GAD), the synthesizing enzyme for gamma-aminobutyric acid (GABA), throughout the visual system of the frog Rana pipiens. GAD-like immunoreactivity (GAD-LI) was assessed in the retina, in primary retinorecipient targets, and in thalamic nuclear groups postsynaptic to primary retinal terminal zones. Within the retina, the inner plexiform layer displayed intense GAD-LI, but immunoreactivity was absent in the ganglion cell layer (GCL). Putative amacrine, bipolar, and horizontal cell somata were also labeled. Centrally, GAD-LI was observed in all primary visual nuclei. Dense, GAD-like immunoreactive punctate structures (puncta), presumably terminals, were observed in the pretectal nucleus lentiformis mesencephali, posterior thalamic neuropil, and uncinate neuropil. GADlike immunoreactive puncta were noted in several laminae of the optic tectum, with the highest concentrations located within the 9th and 8th laminae. Moderate numbers of GAD-like immunoreactive puncta were found in the mesencephalic nucleus of the basal optic root, and two thalamic neuropils—corpus geniculatum and neuropil of Bellonci. The ventrolateral area, posterocentral nucleus, and posterolateral nucleus all contained sparse amounts of GAD-LI. These observations suggest that GABA plays an important physiological role in all central visual areas of Rana pipiens. © 1995 Wiley-Liss, Inc.     

Iopamidol and meglumine diatrizoate: comparison of effects on patient discomfort during aortofemoral arteriography

Iopamidol was compared with Renografin-60 (meglumine diatrizoate, Squibb) in a controlled, randomized double-blind study of 40 patients undergoing peripheral arteriography for arteriosclerotic occlusive disease to determine which agent caused less discomfort. Each patient was evaluated for objective signs of discomfort and subjective feelings of pain and heat. Monitoring was achieved by multiple physical examinations, chemical tests, electrocardiograms, and intra-arterial pressure recordings. It is concluded that iopamidol is safe and causes significantly less patient discomfort than Renografin-60.     

Immunosuppression in renal transplantation: Long-term clinical trial of a double versus triple therapy regimen

Summary: Sixty-nine renal allograft recipients were randomized to two immunosuppressive regimens: 35 patients received cyclosporine A and prednisolone (PC) while 34 patients received low dose cyclosporine A, prednisolone and short term azathioprine (PCA). the data of 66 patients (34 in PC and 32 in PCA groups) were analysed. the median follow-up periods were 62 months for the PC group and 60 months for the PCA group. There was no difference in graft survival between the two groups but five patients died in the PC group compared to none in the PCA group (graft survival: 88 vs 90% at 1 year and 82 vs 82% at 5 years, P = not significant at any time point; patient survival: 90 vs 100% at 1 year and 88 vs 100% at 5 years, P = 0.05 at 5 years). There was a trend for patients in the PCA group to develop earlier and more frequent rejections (not significant; P = 0.106 and P = 0.062, respectively). There were also more episodes of acute cyclosporine A nephrotoxicity and cytomegalovirus (CMV) infection in the PC group. the mean serum creatinine at 5 years was significantly higher in the PCA group when compared to the PC group (179.8 ± 76.5 μmol/L vs 154.7 ± 41.0 μmol/L; P =0.05). We found that both therapeutic regimens were effective in preventing renal allograft rejections. However, double therapy was associated with higher patient mortality secondary to infection. Patients on triple therapy, on the other hand, were more prone to develop rejections in the early post-transplant period and were associated with less favourable renal function in the long run.     

Frostbite: experimental assessment of tissue damage using Tc-99m pyrophosphate. Work in progress

We designed an experimental model using a new method of freezing to study the pathogenesis and treatment of frostbite. Frostbite was simulated in a manner that closely resembles that which occurs in a natural environment. We used a radionuclide imaging technique to monitor the evolution and extent of tissue damage relative to temperature, rate of freezing, and controlled rewarming. Characteristic sequential changes were demonstrated on sequential nuclear scans. Nonperfusion, followed by perfusion, and finally again by nonperfusion occurred in all areas in which necrosis developed. The reappearance of nonperfusion corresponded to vascular injury and thrombosis evidenced at pathologic examination. We determined that lack of tissue perfusion corresponded to tissue injury. We believe that our experimental model provides an effective means of evaluating potential therapeutic regimens.